Signant Health
Dr. Busner has over 30 years of experience as an academic clinical psychiatric researcher. She has served as the Principal Investigator for 49 industry-sponsored psychiatric clinical trials and Sub-Investigator for 35 additional clinical trials. She has served continuously on University Institutional Review Boards (IRBs) for the 20 years that preceded her move to Bracket. Dr. Busner is an active contributor to the psychopharmacology literature and has authored or co-authored over 100 peer-reviewed articles and national or international scientific presentations. Prior to Bracket, Dr. Busner directed the psychiatric clinical trials units of two major medical schools. She serves as Signant’s Expert Presenter and Scientific Lead for US and multinational studies of depressive disorders, anxiety disorders, attention deficit hyperactivity disorder and all child and adolescent psychiatric indications. She has trained thousands of psychiatric clinical trial investigators across the globe and lectures frequently on the application of objective rating scales in the assessment of diagnosis and efficacy in psychopharmacology, ethics in psychiatric research, the placebo effect in psychiatric research and techniques for its minimization, the role of IRBs and clinical trial methodology. Dr. Busner received her PhD in Experimental Social Psychology and her MA in General Psychology from Adelphi University. She is licensed to practice psychology in Pennsylvania, Missouri and New York.
This person is not in any offices
Signant Health
2 followers
Signant Health provides clinical technology to help its customers change lives. For more than 20 years, over 400 biopharmaceutical sponsors and CROs of all sizes, including all of the top 20 pharmaceutical organizations, have trusted our patient solutions, clinical supplies platform, and endpoint quality services to capture reliable data, run efficient trials, and uncover meaningful insights.